Chris Reading

Improved quantitation of minimal residual disease in multiple myeloma using real-time polymerase chain reaction and plasmid-DNA complementarity determining region III standards.

Christopher J. Gerard, K Olsson, Rajeev Ramanathan et al. · PubMed · 1998 · 120 citations

Immunocytochemical Technique, Immunology, Pathology +23

Collection, Tumor Contamination, and Engraftment Kinetics of Highly Purified Hematopoietic Progenitor Cells to Support High Dose Therapy in Multiple Myeloma

Guido Tricot, Yair Gazitt, T Leemhuis et al. · Blood · 1998 · 108 citations

Real-time t(11;14) and t(14;18) PCR assays provide sensitive and quantitative assessments of minimal residual disease (MRD)

K Olsson, CJ Gerard, James L. Zehnder et al. · Leukemia · 1999 · 53 citations

Disease Diagnosis, Engineering, Medical Imaging +12

Differentiation and maturation of growth factor expanded human hematopoietic progenitors assessed by multidimensional flow cytometry.

Leon W.M.M. Terstappen, S Buescher, Mai Ánh Nguyễn et al. · PubMed · 1992 · 47 citations

16α‐Bromoepiandrosterone Restores T Helper Cell Type 1 Activity and Accelerates Chemotherapy‐Induced Bacterial Clearance in a Model of Progressive Pulmonary Tuberculosis

Rogélio Hernández‐Pando, Diana Aguilar‐León, Héctor Orozco et al. · The Journal of Infectious Diseases · 2004 · 47 citations · Full text

Inflammatory Lung Disease, Lung Inflammation, Immunology +17